Medical AI Alliance
Company Index
Medical DevicesKONEX 33604043 approvals

TASCOM Co.,Ltd.

Official website

Develops SimplexTAS, a point-of-care clinical chemistry and immunoassay analyzer for IVD testing.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2014 and listed on KONEX in 2019, Tascom is a medical device company specializing in in vitro diagnostics (IVD). Based on immunological and biochemical biosensor technology, it develops, manufactures, and sells SimplexTAS, a point-of-care testing (POCT) device for diagnosing diabetes, hyperlipidemia, liver disease, kidney disease, infection, and other conditions. SimplexTAS uses capillary blood samples directly, removing blood cell interference through built-in centrifugation, and can analyze up to 4 samples simultaneously; it currently offers 19 developed and registered measurement-item cartridges on sale, with plans to expand to about 40.

Products & technology

  • SimplexTAS (Simple Total Analysis System)Point-of-care clinical chemistry and immunoassay for diabetes, hyperlipidemia, liver disease, kidney disease, and infection

Regulatory approvals

data.go.kr

43 Korean MFDS device approvals · 2016–2026

  • MFDSreagents for clinical enzymes2026-05-06
    Product approval · Class 2체외 제인 26-4397 호
  • MFDSreagents for clinical enzymes2026-04-30
    Product approval · Class 2체외 제인 26-4390 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2022-09-14
    Product approval · Class 2체외 제인 22-4677 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2022-09-14
    Product approval · Class 2체외 제인 22-4676 호
  • MFDSreagents for clinical enzymesRevoked2022-09-14
    Product approval · Class 2체외 제인 22-4675 호
  • MFDSreagents for clinical enzymes2022-09-14
    Product approval · Class 2체외 제인 22-4671 호
  • MFDSreagents for clinical enzymesRevoked2022-09-13
    Product approval · Class 2체외 제인 22-4661 호
  • MFDSreagents for clinical enzymes2022-09-13
    Product approval · Class 2체외 제인 22-4659 호
  • MFDSreagents for clinical enzymes2022-09-05
    Product approval · Class 2체외 제인 22-4642 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2022-08-23
    Product approval · Class 2체외 제인 22-4614 호
  • MFDSIVD reagents for anemia test2021-05-25
    Product approval · Class 2체외 제인 21-4446 호
  • MFDSIVD reagents for inflammatory tests2020-05-15
    Product approval · Class 2체외 제인 20-4384 호
Show 31 more
  • MFDSreagents for clinical enzymes2020-05-15
    Product approval · Class 2체외 제인 20-4380 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2020-05-15
    Product approval · Class 2체외 제인 20-4377 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2020-05-15
    Product approval · Class 2체외 제인 20-4379 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2020-05-15
    Product approval · Class 2체외 제인 20-4381 호
  • MFDSIVD reagents for diabetes mellitus2020-05-15
    Product approval · Class 2체외 제인 20-4382 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2020-05-15
    Product approval · Class 2체외 제인 20-4383 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2020-05-15
    Product approval · Class 2체외 제인 20-4385 호
  • MFDSreagents for clinical enzymes2020-03-20
    Product approval · Class 2체외 제인 20-4221 호
  • MFDSPhotometer for clinical use2020-03-03
    Product approval · Class 1체외 제신 20-264 호
  • MFDSIVD reagents for diabetes mellitus2020-03-03
    Product approval · Class 2체외 제인 20-4172 호
  • MFDSreagents for clinical enzymesRevoked2020-03-03
    Product approval · Class 2체외 제인 20-4174 호
  • MFDSreagents for clinical enzymesRevoked2019-08-26
    Product approval · Class 2체외 제인 19-4714 호
  • MFDSreagents for clinical enzymesRevoked2019-08-23
    Product approval · Class 2체외 제인 19-4711 호
  • MFDSOther Reagents, classⅡ, for clinical chemistryRevoked2019-06-27
    Product approval · Class 2체외 제인 19-4516 호
  • MFDSIVD reagents for electrolyte tests2019-04-22
    Product approval · Class 2체외 제인 19-4314 호
  • MFDSreagents for clinical enzymes2018-11-09
    Product approval · Class 2체외 제인 18-4926 호
  • MFDSreagents for clinical enzymesRevoked2018-11-09
    Product approval · Class 2체외 제인 18-4925 호
  • MFDSreagents for clinical enzymesRevoked2018-11-09
    Product approval · Class 2체외 제인 18-4924 호
  • MFDSIVD reagents for anemia testRevoked2018-11-08
    Product approval · Class 2체외 제인 18-4921 호
  • MFDSIVD reagents for urine chemistry2018-11-08
    Product approval · Class 2체외 제인 18-4920 호
  • MFDSIVD reagents for urine chemistry2018-11-08
    Product approval · Class 2체외 제인 18-4923 호
  • MFDSIVD reagents for inflammatory testsRevoked2018-08-01
    Product approval · Class 2체외 제인 18-4617 호
  • MFDSIVD reagents for general immune testRevoked2017-05-26
    Product approval · Class 2체외 제인 17-4382 호
  • MFDSIVD reagents for general immune testRevoked2017-05-26
    Product approval · Class 2체외 제인 17-4381 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2017-05-26
    Product approval · Class 2체외 제인 17-4384 호
  • MFDSIVD reagents for diabetes mellitusRevoked2016-12-22
    Product approval · Class 2체외 제인 16-988 호
  • MFDSOther Reagents, classⅡ, for clinical chemistry2016-12-22
    Product approval · Class 2체외 제인 16-989 호
  • MFDSIVD reagents for general immune testRevoked2016-12-21
    Product approval · Class 2체외 제인 16-980 호
  • MFDSIVD reagents for general immune testRevoked2016-12-21
    Product approval · Class 2체외 제인 16-981 호
  • MFDSIVD reagents for general immune testRevoked2016-12-21
    Product approval · Class 2체외 제인 16-982 호
  • MFDSPhotometer for clinical use2016-06-10
    Product approval · Class 1체외 제신 16-711 호

R&D and key agreements

Source: DART corporate disclosure

SimplexTAS 시약카트리지 확장 · 당뇨병, 고지혈증, 간질환, 신장질환, 감염 등 · 측정항목 확장개발 중 · Currently sells cartridges for 19 measurement items, with plans to expand to about 40

Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Boditech Med Inc.8 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

GC Medical Science Corporation8 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

SD BIOSENSOR INC.7 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

GENEMATRIX INC.6 shared

KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.

Hanmi Science Co.,Ltd4 shared

KOSPI-listed operating holding company of the Hanmi Pharm group, also running healthcare and pharmaceutical wholesale businesses.

i-SENS, Inc.4 shared

Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.

NanoenTek,Inc.4 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

OSANG HEALTHCARE CO.,LTD.4 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

PCL. Inc4 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

Sugentech, Inc.4 shared

Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.

HUMASIS CO., LTD.3 shared

KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.

QuantaMatrix Incorporated2 shared

Established in 2010, listed on KOSDAQ in 2020, QuantaMatrix develops dRAST and QDST antimicrobial susceptibility testing systems.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition